Nitric oxide: From the mechanism of action to pharmacological effects in cerebrovascular diseases
Фатеева В. В., Воробёва О. В.
Журнал неврологии и психиатрии им. C.C. Корсакова
Т. 117, Вып. 10, С. 131-135
Опубликовано: 2017
Тип ресурса: Обзор
DOI:10.17116/jnevro2017117101131-135
Аннотация:
The article presents the data of studies of nitric oxide (NO) in the pathogenesis of cerebrovascular diseases. It is emphasized that endothelial dysfunction contributes to the formation of cerebrovascular diseases. Generalized data on preparations with endothelioprotective effect, as well as own data on the use of the preparation ≪Divaza≫ in patients of middle and advanced age with chronic cerebrovascular disease are given. © 2017, Media Sphera Publishing Group. All rights reserved.
Ключевые слова:
Cerebrovascular diseases; Divazа; Endothelial dysfunction; Nitric oxide; Prooxidant and antioxidant systems; Therapeutic strategies
nitric oxide; angiotensin 1 receptor antagonist; antibody; dipeptidyl carboxypeptidase inhibitor; divaza; hydroxymethylglutaryl coenzyme A reductase inhibitor; nitric oxide; cerebrovascular disease; chronic disease; endothelial dysfunction; human; pathogenesis; Review; cerebrovascular disease; combination drug therapy; pathophysiology; physiology; vascular endothelium; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antibodies; Cerebrovascular Disorders; Drug Therapy, Combination; Endothelium, Vascular; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Nitric Oxide
Язык текста: Русский
ISSN: 2309-4729
Фатеева В. В. Виктория Вячеславовна 1988-
Воробёва О. В.
Fateeva V. V. Viktoriya Vyacheslavovna 1988-
Vorobyova O. V.
Nitric oxide: From the mechanism of action to pharmacological effects in cerebrovascular diseases
Текст визуальный непосредственный
Журнал неврологии и психиатрии им. C.C. Корсакова
Издательство Медиа Сфера
Т. 117, Вып. 10 С. 131-135
2017
Обзор
Cerebrovascular diseases Divazа Endothelial dysfunction Nitric oxide Prooxidant and antioxidant systems Therapeutic strategies
nitric oxide angiotensin 1 receptor antagonist antibody dipeptidyl carboxypeptidase inhibitor divaza hydroxymethylglutaryl coenzyme A reductase inhibitor nitric oxide cerebrovascular disease chronic disease endothelial dysfunction human pathogenesis Review cerebrovascular disease combination drug therapy pathophysiology physiology vascular endothelium Angiotensin II Type 1 Receptor Blockers Angiotensin-Converting Enzyme Inhibitors Antibodies Cerebrovascular Disorders Drug Therapy, Combination Endothelium, Vascular Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors Nitric Oxide
The article presents the data of studies of nitric oxide (NO) in the pathogenesis of cerebrovascular diseases. It is emphasized that endothelial dysfunction contributes to the formation of cerebrovascular diseases. Generalized data on preparations with endothelioprotective effect, as well as own data on the use of the preparation ≪Divaza≫ in patients of middle and advanced age with chronic cerebrovascular disease are given. © 2017, Media Sphera Publishing Group. All rights reserved.